Use of multiple sclerosis disease-modifying therapies during pregnancy in France: Nationwide study between 2010 and 2021.

Morgane SwitalJérôme DrouinSara MirandaSerge BakchineJérémie Botton Rosemary Dray-Spira

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2024)

Despite MS therapeutic management adaptations to pregnancy, exposure during pregnancy to treatments whose safety profile has not yet been clearly established has increased sharply over the last decade.

Keyphrases

multiple sclerosis
white matter
preterm birth
mass spectrometry
high intensity
pregnancy outcomes
ms ms
pregnant women